openPR Logo
Press release

Myelodysplastic Syndrome (MDS) Treatment Industry to Witness Massive Growth (2024-2031) | AbbVie Inc., Accord Healthcare, Bristol-Myers Squibb, Jazz Pharmaceuticals Inc., Novartis AG

08-14-2024 11:27 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Myelodysplastic Syndrome (MDS) Treatment Industry to Witness

DataM Intelligence has published a new research report on "Myelodysplastic Syndrome (MDS) Treatment Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/myelodysplastic-syndrome-treatment-market

The Myelodysplastic Syndrome (MDS) Treatment market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.

Myelodysplastic syndrome (MDS) treatment involves managing a group of disorders characterized by the bone marrow's inability to produce enough healthy blood cells. Treatment options for MDS vary depending on the severity of the disease, the patient's age, and overall health, and may include supportive care, medications, and sometimes stem cell transplantation. Supportive care includes blood transfusions and medications to manage symptoms like anemia or infections

Forecast Growth Projected:

The Global Myelodysplastic Syndrome (MDS) Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

List of the Key Players in the Myelodysplastic Syndrome (MDS) Treatment Market:

AbbVie Inc., Accord Healthcare, Bristol-Myers Squibb, Jazz Pharmaceuticals Inc., Novartis AG, Lupin Pharmaceuticals, Otsuka America Pharmaceutical Inc., Onconova Therapeutics, Takeda Pharmaceutical Company Limited, and Astex Pharmaceuticals, Inc.

Segment Covered in the Myelodysplastic Syndrome (MDS) Treatment Market:

By Treatment Type: Stem Cell Transplant, Immune Treatments, Chemotherapy (Hypomethylating Agents (Azacitidine (Vidaza), Decitabine (Dacogen)), Immunomodulatory Drugs (Lenalidomide (Revlimid), Others), Anti-anemics (Luspatercept-AAMT (REBLOZYL®), Others), Others (Cytarabine (Cytosar-U), Daunorubicin (Cerubidine), Idarubicin (Idamycin), INQOVI® (ASTX727))), Growth factors, Others

By End-User: Hospitals, Specialty Clinics, Others

Regional Analysis:

The global Myelodysplastic Syndrome (MDS) Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/myelodysplastic-syndrome-treatment-market

Regional Analysis:

The global Myelodysplastic Syndrome (MDS) Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Myelodysplastic Syndrome (MDS) Treatment Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Myelodysplastic Syndrome (MDS) Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Myelodysplastic Syndrome (MDS) Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/myelodysplastic-syndrome-treatment-market

FAQs

How big is the Myelodysplastic Syndrome (MDS) Treatment Market?

The Myelodysplastic Syndrome (MDS) Treatment Market size was USD $ 3,065.5 million in 2023. It is expected to reach USD $ 6,059.5 million by 2031.

How fast is the Myelodysplastic Syndrome (MDS) Treatment Market growing?

The Myelodysplastic Syndrome (MDS) Treatment Market will exhibit a CAGR of 9.1% during the forecast period, 2024-2031.

Read Latest Blog: https://www.datamintelligence.com/blogs/top-10-process-automation-companies-worldwide

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Myelodysplastic Syndrome (MDS) Treatment Industry to Witness Massive Growth (2024-2031) | AbbVie Inc., Accord Healthcare, Bristol-Myers Squibb, Jazz Pharmaceuticals Inc., Novartis AG here

News-ID: 3622940 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Immunohistochemistry Market 2026 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
United States Immunohistochemistry Market 2026 | Growth Drivers, Trends & Market …
Market Size and Growth The Global Immunohistochemistry Market size was valued at US$ 2,302.79 million in 2022 and is estimated to reach US$4,240.65 million by 2031, growing at a CAGR of 8.1% during the forecast period (2024-2031). Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/immunohistochemistry-market?sb Key Development: United States: Recent Industry Developments ✅ In February 2026, the U.S. Food and Drug Administration approved PD‐L1 IHC 22C3 pharmDx
Critical Minerals Market to Reach US$ 586.63 Billion by 2032; Asia Pacific Leads with 35% Share | Key Players: Albemarle Corporation, China Northern Rare Earth, MP Materials
Critical Minerals Market to Reach US$ 586.63 Billion by 2032; Asia Pacific Leads …
Market Overview Market Size (2024): USD 328.19 billion Expected Market Size (2032): USD 586.63 billion CAGR (2025-2032): 7.53% The global critical minerals market is experiencing unprecedented growth, driven primarily by the accelerating transition to clean energy technologies. Key energy transition minerals including lithium, cobalt, and nickel have seen rapid demand growth: lithium demand has tripled, cobalt demand has risen by 70%, and nickel demand has increased by 40% between 2017 and 2022. Clean energy
Drug of Abuse Testing Market to Reach US$ 12.31 Billion by 2033; North America Leads with 40% Share | Key Players: Siemens Healthcare, Thermo Fisher Scientific, Abbott
Drug of Abuse Testing Market to Reach US$ 12.31 Billion by 2033; North America L …
Market Overview Market Size (2023): USD 7.26 billion Expected Market Size (2033): USD 12.31 billion CAGR (2025-2033): 5.3% Drug abuse testing is a critical process for detecting prescription and illicit substances in an individual's system, ensuring safety, regulatory compliance, and medical evaluation. It is widely used across workplace screening, forensic investigations, sports anti-doping programs, and clinical diagnostics. Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/drug-of-abuse-testing-market?Juli Advancements in rapid detection
United States Aesthetic Lasers and Energy Devices Market 2026 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
United States Aesthetic Lasers and Energy Devices Market 2026 | Growth Drivers, …
Market Size and Growth Aesthetic Lasers and Energy Devices Market is estimated to reach at a CAGR of 6.40% during the forecast period (2024-2031). Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/aesthetic-lasers-and-energy-devices-market?sb Key Development: United States: Recent Industry Developments ✅ In November 2025, Venus Concept Inc. secured FDA 510(k) clearance for its Venus NOVATM platform, a next‐generation multi‐application device combining radiofrequency, EMS, and electromagnetic technologies for non‐invasive

All 5 Releases


More Releases for Treatment

Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any